Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Clinical Science (London, England : 1979)|September 27, 2021
Imatinib protects against human beta-cell death via inhibition of mitochondrial respiration and activation of AMPKAndris Elksnis, Tomas A Schiffer, Fredrik Palm, et al.
Frontiers in Endocrinology|July 19, 2024
Rise in fasting and dynamic glucagon levels in children and adolescents with obesity is moderate in subjects with impaired fasting glucose but accentuated in subjects with impaired glucose tolerance or type 2 diabetesThomas Pixner, Tatsiana Chaikouskaya, Wanda Lauth, et al.
Annals of Nutrition & Metabolism|October 26, 2023
Screening for Inflammatory Markers Identifies IL-18Rα as a Potential Link between Exenatide and Its Anti-Inflammatory Effect: New Results from the Combat-JUDO Randomized Controlled TrialRasmus Stenlid, Sara Y Cerenius, Hannes Manell, et al.
Cardiovascular Diabetology|August 9, 2025
Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDSRasmus Stenlid, Sami El Amrani, Sara Y Cerenius, et al.
Pediatric Diabetes|July 5, 2019
Hyperglucagonemia in youth is associated with high plasma free fatty acids, visceral adiposity, and impaired glucose toleranceHannes Manell, Hjalti Kristinsson, Joel Kullberg, et al.
Nutrients|January 11, 2022
Association between Metabolic Syndrome Diagnosis and the Physical Activity-Sedentary Profile of Adolescents with Obesity: A Complementary Analysis of the Beta-JUDO StudyValérie Julian, Iris Ciba, Roger Olsson, et al.
Pediatric Diabetes|October 23, 2020
Prevalence of different states of glucose intolerance in Sri Lankan children and adolescents with obesity and its relation to other comorbiditiesIris Ciba, Loretta S Warnakulasuriya, Adikaram V N Adikaram, et al.
Frontiers in Endocrinology|November 29, 2023
Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic controlRasmus Stenlid, Sara Y Cerenius, Quan Wen, et al.
Obesity Facts|June 2, 2026
The GLP-1 agonist exenatide is associated with improved adherence to health behavior and lifestyle treatment in adolescents with obesity, a randomized controlled trialRasmus Stenlid, Sara Y Cerenius, Gabriel Torbahn, et al.
Asia-Pacific Journal of Public Health|September 19, 2019
Assessment of Nutritional Status in Sri Lankan Children: Validity of Current Anthropometry Cutoffs?Loretta S Warnakulasuriya, Manel A M Fernando, A V Nihal Adikaram, et al.
Pageof 10